ALNYLAM PHARMACEUTICALS, INC.: net_income
| Value | {"amount": -47590000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2009-01-01 – 2009-12-31 |
| Status | current |
| Entity | ALNYLAM PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:51:48.525796+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/64793331-5b82-44b9-93b6-724d81d34ae2
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950123-11-015737Retrieved: 2026-08-19T11:51:48.525796+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001178670/net-income/2009-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/64793331-5b82-44b9-93b6-724d81d34ae2
History
- no predecessors — first report